Iovance Biotherapeutics (NASDAQ: IOVA) is a biotech company with an innovative approach to developing cancer medicines.

Avantax Advisory Services Inc. increased its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 5.7% ...

Analysts at Craig Hallum assumed coverage on shares of Veracyte (NASDAQ:VCYT – Get Free Report) in a note issued to investors ...

There’s been no shortage of either in recent weeks. Plunging valuations across the biotech sector were thrust into the ...

The biotechnology sector is gaining new momentum with better market conditions, cutting-edge innovations, and growing investor attention.

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

Here’s what happened after RFK Jr. paused Peninsula company's half-billion-dollar vaccine contract. Spoiler alert: It wasn’t ...

Adaptive Biotechnologies (NASDAQ:ADPT) stock rises as Goldman Sachs upgrades to 'Buy,' citing an attractive end market. Read more here.

Biotech stocks are among the few industry groups producing breakouts and buyable stocks in an uncertain market. Vertex stock ...

Delving into the details, we found 40% of traders were bullish, while 50% showed bearish tendencies. Out of all the trades we ...

Discover three undervalued biotech stocks with strong assets, solid cash reserves, and major catalysts ahead. Click for the ...

The Fed kept rates unchanged for now, a move that was widely expected. It did note, though, that “uncertainty around the ...